XBIO ▲ +4.0% - Xenetic Biosciences, Inc. $XBIO - Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance 04-NOV-2026 09:20 AM ET